ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Anormed Ord (MM)

Anormed Ord (MM) (ANOR)

0.00
0.00
(0.00%)
終了 1月24日 6:00AM
0.00
0.00
( 0.00% )
プレマーケット: -

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
-
買値
-
売値
-
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
-
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

ANOR 最新ニュース

Genzyme Completes Tender Offer for Outstanding Shares of AnorMED

Acquisition to Strengthen Transplant and Oncology Businesses CAMBRIDGE, Mass. and VANCOUVER, B.C., Nov. 7 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) and AnorMED Inc. (Nasdaq:...

Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review

CAMBRIDGE, Mass. and VANCOUVER, B.C., Nov. 7 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) and AnorMED Inc. (Nasdaq: ANOR; TSX: AOM) announced today the expiration of the waiting...

AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events

AnorMED Board Recommends Shareholders Accept Genzyme Offer LANGLEY, BC, Nov. 3 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or the "Company") (NASDAQ:ANOR; TSX:AOM) today released its...

Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer

SEATTLE, Oct. 26 /PRNewswire/ -- Koronis Pharmaceuticals, Inc. today announced the appointment of Stephen Becker, M.D., as chief medical officer. Dr. Becker joins Koronis from AnorMED...

AnorMED completes enrollment in Phase III trial for MOZOBIL on schedule

VANCOUVER, Oct. 23 /PRNewswire-FirstCall/ -- AnorMED Inc. (NASDAQ:ANOR; TSX:AOM) today announced that it has completed enrollment in the second pivotal Phase III clinical trial evaluating its...

AnorMED and Genzyme reach agreement on acquisition

Genzyme to Gain Late-Stage Transplantation Product Candidate VANCOUVER, BC, and CAMBRIDGE, MA, Oct. 17 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) and AnorMED Inc. (Nasdaq: ANOR;...

AnorMED has determined Genzyme's offer is a 'superior proposal'

Millennium has the right to match Genzyme's 'superior proposal' VANCOUVER, Oct. 11 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or "the Company") (NASDAQ:ANOR; TSX:AOM) announced that it...

AnorMED has determined Genzyme's offer is a 'superior proposal'

Millennium has the right to match Genzyme's 'superior proposal' VANCOUVER, Oct. 11 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or "the Company") (NASDAQ:ANOR; TSX:AOM) announced that it...

AnorMED announces receipt of proposal from Genzyme Corporation

VANCOUVER, Oct. 10 /PRNewswire-FirstCall/ -- AnorMED Inc. (NASDAQ:ANOR; TSX:AOM) announced today that it has received a proposal from Genzyme Corporation (NASDAQ:GENZ), acting through its wholly...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ANOR - Frequently Asked Questions (FAQ)

What is the current share price?
The current share price of is US$ 0.00
What is the 1 year trading range for share price?
has traded in the range of US$ 0.00 to US$ 0.00 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
STBXStarBox Group Holdings Ltd
US$ 0.9802
(92.16%)
824.04k
DWTXDogwood Therapeutics Inc
US$ 23.19
(73.71%)
318.52k
BTAIBioXcel Therapeutics Inc
US$ 0.5813
(53.05%)
935.05k
EVAXEvaxion Biotech AS
US$ 4.70
(29.12%)
117.34k
NVNINVNI Group Ltd
US$ 1.88
(26.17%)
154.81k
HYZNHyzon Motors Inc
US$ 0.5001
(-35.22%)
9.06k
XNCRXencor Inc
US$ 15.01
(-26.64%)
1
LITMSnow Lake Resources Ltd
US$ 1.02
(-26.62%)
771.45k
EWTXEdgewise Therapeutics Inc
US$ 22.01
(-18.48%)
1
ZBAIATIF Holdings Ltd
US$ 1.05
(-17.97%)
12
ACONAclarion Inc
US$ 0.0481
(11.34%)
1.64M
BTAIBioXcel Therapeutics Inc
US$ 0.5813
(53.05%)
935.05k
STBXStarBox Group Holdings Ltd
US$ 0.9802
(92.16%)
824.04k
LITMSnow Lake Resources Ltd
US$ 1.02
(-26.62%)
771.45k
SHViShares Short Treasury Bond ETF
US$ 110.42
(0.04%)
515.62k